Has Dmitry Arbuck, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,382 in general payments to Dmitry Arbuck, MD across 1,030 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dmitry Arbuck, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dmitry Arbuck, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dmitry Arbuck, MD

Psychiatry · Indianapolis, INNPI 1700872033

Payments from drug & device makers

$40,382in general payments, 2019–2025

Across 1,030 payments — averaging $39.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$25K
Teva Pharmaceuticals USA, Inc.$3K
Biodelivery Sciences International, Inc.$2K
Neurocrine Biosciences, Inc.$1K
Vanda Pharmaceuticals Inc.$1K
Lundbeck LLC$896
plus $8K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	242	$24,630
Teva Pharmaceuticals USA, Inc.	157	$2,698
Biodelivery Sciences International, Inc.	10	$1,600
Neurocrine Biosciences, Inc.	71	$1,210
Vanda Pharmaceuticals Inc.	43	$1,202
Lundbeck LLC	59	$896
Amgen(2 entities)	27	$617
Eisai Inc.	29	$490
Pfizer	41	$483
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	21	$477
Merck	27	$412
Boston Scientific	18	$405
Otsuka America Pharmaceutical, Inc.	15	$336
Collegium Pharmaceutical, Inc.	15	$267
GRT US Holding, Inc.	12	$259
Harmony Biosciences LLC	14	$253
Sunovion Pharmaceuticals Inc.	9	$249
AstraZeneca(2 entities)	10	$246
Johnson & Johnson	15	$235
Scilex Pharmaceuticals Inc.	17	$230
Biohaven Pharmaceutical Holding Company Ltd.	15	$220
E.r. Squibb & Sons, L.L.C.	6	$218
ANI Pharmaceuticals, Inc.	5	$218
Takeda Pharmaceuticals U.S.A., Inc.	12	$208
Biohaven Pharmaceuticals, Inc.	14	$198
Impel Pharmaceuticals Inc.	18	$192
Axsome Therapeutics, Inc.	9	$191
MDD US Operations, LLC	8	$129
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	7	$118
Indivior Inc.	8	$118
Bioventus LLC	5	$113
Arbor Pharmaceuticals, Inc.	2	$111
Novartis	6	$101
Orexo US, Inc.	7	$97
Jazz Pharmaceuticals Inc.	4	$89
Supernus Pharmaceuticals, Inc.	5	$84
Lilly USA, LLC	5	$73
Tersera Therapeutics LLC	4	$72
Livanova USA, Inc.	3	$65
Almatica Pharma LLC	3	$57
Pacira Therapeutics, Inc.	4	$53
Alkermes, Inc.	2	$52
Si-bone, Inc.	2	$50
Pacira Pharmaceuticals Incorporated	3	$47
Alfasigma USA, Inc.	3	$46
Radius Health, Inc.	3	$45
Averitas Pharma Inc.	2	$45
Upsher-smith Laboratories LLC	2	$36
Idorsia Pharmaceuticals US Inc	2	$31
Zyla Life Sciences, Inc.	2	$24
IBSA Pharma Inc.	1	$18
Medtronic	1	$17
SPR Therapeutics, Inc	1	$16
Kaleo, Inc.	1	$13
Shionogi Inc	1	$11
Fidia Pharma USA Inc.	2	$10

How this compares

$40,382 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana →

Medicare billing

Part B allowed, 2024

$224,883

Medicare patients

387

Services billed

2,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Indianapolis

Anantha ShekharIndianapolis$433K
Leslie HulvershornIndianapolis$159K
Charles BeasleyIndianapolis$129K
Alan BreierIndianapolis$114K
John NurnbergerIndianapolis$104K
Susan ConroyIndianapolis$73K
Michael FrancisIndianapolis$26K
Albert AllenIndianapolis$24K
Jerad DaltonIndianapolis$20K
Thomas McAllisterIndianapolis$16K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →